Chelsea Therapeutics Logo

Chelsea Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference

| Source: Chelsea Therapeutics

CHARLOTTE, N.C., Feb. 16, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced Dr. Simon Pedder, president and CEO, is scheduled to present at the Leerink Swann 2012 Global Healthcare Conference at 2:30 PM ET on Thursday, February 16, 2012 at the Waldorf Astoria Hotel in New York.

Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at:

About Chelsea Therapeutics

Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical development company that acquires and develops innovative products for the treatment of a variety of human diseases, including central nervous system, rheumatoid arthritis, psoriasis and other inflammatory diseases. Founded in 2004 around its library of unique anti-inflammatory and autoimmune technology, Chelsea has further expanded its product development portfolio with early- and late-stage candidates that leverage the company's development expertise and accelerate the company's drug commercialization efforts. For more information about the company, visit

This press release contains forward-looking statements regarding future events. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include risk of regulatory approvals; risks and costs of drug development, including the uncertainty of cost, timing and outcome of clinical trials; our need to raise operating capital; our reliance on our lead drug candidates droxidopa and CH-4051; our history of losses; reliance on collaborations and licenses; intellectual property risks; competition; market acceptance for our products, if any are approved for marketing; and reliance on key personnel including specifically Dr. Pedder.

Kathryn McNeil
Chelsea Therapeutics

Lauren Tortorete
Hill & Knowlton